Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Insurance Industry Analysis

UpdatedMar 12, 2026
DataAggregated Company Financials
Companies129
  • 7D-4.6%
  • 3M-6.3%
  • 1Y-8.6%
  • YTD-5.3%

Over the last 7 days, the Insurance industry has dropped 4.6%, and Progressive contributed the most with a 4.8% decline. In contrast, Health In Tech has gained 22%. The industry has fallen 8.6% in the last year. As for the next few years, earnings are expected to grow by 3.8% per annum.

Industry Valuation and Performance

Has the U.S. Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 12 Mar 2026US$1.3tUS$946.2bUS$105.4b11.4x12.4x1.4x
Sat, 07 Feb 2026US$1.4tUS$946.4bUS$107.0b12.9x12.8x1.5x
Mon, 05 Jan 2026US$1.4tUS$931.1bUS$99.3b12.9x13.9x1.5x
Wed, 03 Dec 2025US$1.4tUS$931.0bUS$99.2b13.1x13.8x1.5x
Fri, 31 Oct 2025US$1.3tUS$926.2bUS$92.5b13.2x14.2x1.4x
Sun, 28 Sep 2025US$1.4tUS$919.1bUS$88.7b13.6x15.9x1.5x
Tue, 26 Aug 2025US$1.4tUS$918.4bUS$88.5b14.6x16x1.5x
Thu, 24 Jul 2025US$1.4tUS$910.3bUS$85.7b14.5x16.3x1.5x
Sat, 21 Jun 2025US$1.4tUS$904.1bUS$82.6b14.1x17.1x1.6x
Mon, 19 May 2025US$1.5tUS$902.8bUS$82.1b15.2x17.7x1.6x
Wed, 16 Apr 2025US$1.4tUS$897.3bUS$92.9b13.4x15.5x1.6x
Fri, 14 Mar 2025US$1.4tUS$897.4bUS$93.0b12.8x15.3x1.6x
Sun, 09 Feb 2025US$1.4tUS$904.8bUS$95.8b12.4x14.7x1.6x
Tue, 07 Jan 2025US$1.4tUS$892.9bUS$91.5b13x14.9x1.5x
Thu, 05 Dec 2024US$1.5tUS$893.2bUS$91.1b13.4x15.9x1.6x
Sat, 02 Nov 2024US$1.4tUS$884.9bUS$89.5b13.3x15.3x1.5x
Mon, 30 Sep 2024US$1.4tUS$855.0bUS$87.4b13.9x15.9x1.6x
Wed, 28 Aug 2024US$1.4tUS$855.4bUS$87.0b14x15.6x1.6x
Fri, 26 Jul 2024US$1.2tUS$828.3bUS$81.5b13x14.8x1.5x
Sun, 23 Jun 2024US$1.2tUS$823.4bUS$79.2b13.1x15x1.4x
Tue, 21 May 2024US$1.2tUS$823.1bUS$79.1b12.5x15.2x1.5x
Thu, 18 Apr 2024US$1.1tUS$797.1bUS$68.9b14.6x16.3x1.4x
Sat, 16 Mar 2024US$1.2tUS$792.5bUS$66.9b14.4x17.5x1.5x
Mon, 12 Feb 2024US$1.1tUS$784.4bUS$61.3b12.2x18.1x1.4x
Wed, 10 Jan 2024US$1.1tUS$790.2bUS$48.8b12.7x22.7x1.4x
Fri, 08 Dec 2023US$1.1tUS$792.7bUS$47.5b13.1x23x1.4x
Sun, 05 Nov 2023US$1.1tUS$790.3bUS$46.8b12.8x22.7x1.3x
Tue, 03 Oct 2023US$1.0tUS$799.1bUS$38.9b14.5x26.4x1.3x
Thu, 31 Aug 2023US$1.0tUS$799.3bUS$38.7b15.2x26.5x1.3x
Sat, 29 Jul 2023US$1.0tUS$791.2bUS$41.3b15.6x24.7x1.3x
Mon, 26 Jun 2023US$964.1bUS$774.5bUS$35.1b15.7x27.4x1.2x
Wed, 24 May 2023US$959.6bUS$774.0bUS$35.6b15.4x27x1.2x
Fri, 21 Apr 2023US$987.7bUS$760.4bUS$44.2b15.9x22.3x1.3x
Sun, 19 Mar 2023US$905.6bUS$759.4bUS$44.2b14.5x20.5x1.2x
Price to Earnings Ratio

20.5x


Total Market Cap: US$905.6bTotal Earnings: US$44.2bTotal Revenue: US$759.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Insurance Industry Price to Earnings3Y Average 18.2x202420252026
Current Industry PE
  • Investors are pessimistic on the American Insurance industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.4x which is lower than its 3-year average PE of 18.2x.
  • The industry is trading close to its 3-year average PS ratio of 1.5x.
Past Earnings Growth
  • The earnings for companies in the Insurance industry have grown 34% per year over the last three years.
  • Revenues for these companies have grown 7.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Financials industry?

US Market-1.47%
Financials-3.73%
Insurance-4.56%
General Insurance-2.89%
Reinsurance-3.15%
Life and Health Insurance-3.93%
Property and Casualty Insurance-4.18%
Insurance Brokers-6.25%
Industry PE
  • Investors are most optimistic about the Insurance Brokers industry even though it's trading below its 3-year average PE ratio of 36.7x.
    • Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 39.2% per year.
  • Investors are most pessimistic about the Reinsurance industry, which is trading below its 3-year average of 14.2x.
Forecasted Growth
  • Analysts are most optimistic on the Insurance Brokers industry, expecting annual earnings growth of 13% over the next 5 years.
  • However this is lower than its past earnings growth rate of 39% per year.
  • In contrast, the Property and Casualty Insurance industry is expected to see its earnings decline by 2.2% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HIT Health In TechUS$1.9822.2%
+US$20.5m		50.0%PE78.4x
GBLI Global Indemnity GroupUS$29.565.0%
+US$20.2m		-19.1%PE17x
GLRE Greenlight Capital ReUS$14.883.6%
+US$16.0m		15.8%PE6.8x
ABX Abacus Global ManagementUS$10.101.6%
+US$15.6m		37.2%PE89.4x
GOCO GoHealthUS$1.849.5%
+US$2.6m		-85.9%PS0.04x

Latest News

CB
US$322.76
Chubb
7D
-3.4%
1Y
13.7%

CB: Dividends And Buybacks Will Support A Stable Fairly Valued Outlook

Analysts have nudged their price target on Chubb slightly higher to about $338 from roughly $336, attributing the change to small adjustments in expected revenue trends, profit margins, and future P/E assumptions. What's in the News Chubb's Board of Directors plans to recommend at the 2026 Annual General Meeting an annual dividend of $4.08 per share, payable in four quarterly payments of $1.02 per share, compared with the current quarterly dividend of $0.97 per share.
GBLI
US$29.56
Global Indemnity Group
7D
5.0%
1Y
-19.1%
GLRE
US$14.88
Greenlight Capital Re
7D
3.6%
1Y
15.8%
AON
US$316.90
Aon
7D
-7.1%
1Y
-20.4%
MRSH
US$173.97
Marsh & McLennan Companies
7D
-5.9%
1Y
-24.3%
HIT
US$1.98
Health In Tech
7D
22.2%
1Y
50.0%
PGR
US$201.22
Progressive
7D
-4.8%
1Y
-27.5%

PGR: Softening Cycle And Policy Momentum Will Support Future Earnings Power

The Analyst Price Target for Progressive edges down by about $1 to $238.10 as analysts factor in slightly lower valuation multiples, modestly softer premium growth, and more conservative assumptions for net investment income, while still recognizing steady policy growth and profitability expectations reflected in recent Street research. Analyst Commentary Recent research shows a mix of cautious tweaks and ongoing confidence in Progressive, with most firms trimming price targets rather than making wholesale changes to their broader views on the business.
ABX
US$10.10
Abacus Global Management
7D
1.6%
1Y
37.2%

ABX: Share Repurchase Plan Will Support Forward Upside Potential

Analysts have lifted their price target on Abacus Global Management to $11.00, reflecting updated assumptions for slightly higher revenue growth, a modestly stronger profit margin profile, and a marginally lower future P/E multiple. What's in the News Abacus Global Management, Inc.
AJG
US$209.84
Arthur J. Gallagher
7D
-7.0%
1Y
-35.4%

AJG: Margin Durability And Softer Cycle Are Expected To Support 2026 Upside

Narrative Update: Arthur J. Gallagher (AJG) The analyst price target for Arthur J.
ALL
US$205.59
Allstate
7D
-4.0%
1Y
3.7%

ALL: Thinner Profit Margins Will Constrain Future Upside Potential

Narrative Update on Allstate Analysts have made a slight trim to their Allstate price target to about $189, reflecting updated assumptions around revenue, profit margins, and future P/E expectations. What's in the News The Allstate Corporation declared a quarterly dividend of US$1.08 per share, scheduled to be paid on April 1, 2026.
MET
US$69.96
MetLife
7D
-4.6%
1Y
-11.6%

MET: Buybacks And Retirement Income Agreements Will Drive Future Upside

Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.
GOCO
US$1.84
GoHealth
7D
9.5%
1Y
-85.9%

GOCO: Stronger Margins And Lower P E Will Support Future Cash Flow

Analysts have trimmed their price target on GoHealth to reflect slightly weaker revenue expectations, a modestly stronger profit margin, and a marginally lower forward P/E. This results in a small downward adjustment in their $ price outlook for the stock.
TRV
US$299.40
Travelers Companies
7D
-4.0%
1Y
18.8%
AAME
US$2.68
Atlantic American
7D
2.3%
1Y
84.8%

Investors Still Aren't Entirely Convinced By Atlantic American Corporation's (NASDAQ:AAME) Revenues Despite 39% Price Jump

Dec 20
Investors Still Aren't Entirely Convinced By Atlantic American Corporation's (NASDAQ:AAME) Revenues Despite 39% Price Jump